Table 2 Correlation of clinicopathological and miR factors with clinical outcome in validation cohort (n = 114).

From: An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation

 

RFS

Univariate

Multivariable

OS

Univariate

Multivariable

Age (>60 vs ≤ 60)

>60

HR = 1.02, P = 0.935

 

>60

HR = 1.17, P = 0.590

 

95%CI:0.59–1.83

95%CI:0.67–2.15

Race (AA vs non-AA)

AA

HR = 1.06, P = 0.852

 

AA

HR = 1.14, P = 0.692

 

95%CI:0.54–1.94

95%CI:0.58–2.09

Gender (Female vs Male)

Male

HR = 1.20, P = 0.498

 

Male

HR = 1.21, P = 0.479

 

95%CI:0.71–2.06

95%CI:0.71–2.09

Smoking history (Yes vs No)

Yes

HR = 1.29, P = 0.344

 

Yes

HR = 1.33, P = 0.291

 

95%CI:0.76–2.23

95%CI:0.78–2.31

Alcohol history (Yes vs No)

Yes

HR = 1.77, P = 0.042

 

Yes

HR = 1.50, P = 0.141

 

95%CI:1.023.21

95%CI:0.88–2.65

Histology (SCC vs ADC)

SCC

HR = 1.61, P = 0.075

HR = 1.92,

SCC

HR = 1.71, P = 0.048

HR = 2.16,

95%CI:0.95–2.72

P = 0.017

95%CI:1.012.90

P = 0.006

95%CI:1.133.26

95%CI:1.263.72

Differentiation (Poor vs Well/Mod)

Poor

HR = 2.71, P = 0.001

 

Poor

HR = 2.42, P = 0.042

 

95%CI:1.514.69

95%CI:1.344.21

TNM stage (II/III/IV vs I)

II–IV

HR = 2.45, P < 0.001

HR = 2.74,

II–IV

HR = 2.11, P = 0.006

HR = 2.41,

95%CI:1.444.21

P < 0.001

95%CI:1.243.63

P = 0.002

95%CI:1.604.75

95%CI:1.404.22

miR-21 (High vs Low)

High

HR = 1.65, P = 0.093

 

High

HR = 1.61, P = 0.110

 

95%CI:0.92–3.14

95%CI:0.90–3.07

miR-23b (High vs Low)

High

HR = 1.87, P = 0.028

HR = 2.40,

High

HR = 1.93, P = 0.019

HR = 2.35,

95%CI:1.073.18

P = 0.005

95%CI:1.123.30

P = 0.005

95%CI:1.324.29

95%CI:1.304.19

miR-31 (High vs Low)

High

HR = 1.22, P = 0.485

 

High

HR = 1.70, P = 0.081

 

95%CI:0.70–2.21

95%CI:0.94–3.29

miR-126 (High vs Low)

Low

HR = 1.42, P = 0.203

 

Low

HR = 1.31, P = 0.329

 

95%CI:0.83–2.52

95%CI:0.77–2.31

miR-145 (High vs Low)

Low

HR = 1.07, P = 0.844

 

Low

HR = 1.02, P = 0.961

 

95%CI:0.58–2.11

95%CI:0.56–1.97

miR-150 (High vs Low)

Low

HR = 1.58, P = 0.104

HR = 1.92,

Low

HR = 1.49, P = 0.173

HR = 1.94,

95%CI:0.91–2.70

P = 0.034

95%CI:0.83–2.56

P = 0.038

95%CI:1.053.47

95%CI:1.043.56

miR-205 (High vs Low)

High

HR = 1.22, P = 0.459

 

High

HR = 1.39, P = 0.228

 

95%CI:0.72–2.06

95%CI:0.81–2.35

miR-296 (High vs Low)

High

HR = 1.13, P = 0.833

 

High

HR = 1.22, P = 0.725

 

95%CI:0.42–4.65

95%CI:0.45–5.03

  1. AA: African-American, ADC: adenocarcinoma, SCC: squamous cell carcinoma, N.S.: not significant, Hazard ratios, 95% confidence intervals and P values were obtained using Cox proportional hazards models for RFS and OS. If significant displayed bold.